Competitive analysis in Pain/Inflammation Drugs industry

Top companies filing patent oppositions

Total Oppositions
6
Total Oppositions
4
Company
Total Oppositions
4
Total Oppositions
3
Total Oppositions
3
Total Oppositions
3
Total Oppositions
3
Total Oppositions
3
Total Oppositions
3
Total Oppositions
2

Top companies facing patent oppositions

Total Oppositions
8
Total Oppositions
8
Total Oppositions
5
Total Oppositions
5
Total Oppositions
4
Total Oppositions
4
Total Oppositions
3

Latest patents granted in the Pain/inflammation Drugs industry

Patent:
Grant Date:
Aug 28, 2024
Title:
New (Trimethoxyphenylamino)Pyrimidinyl Formulations
Patent:
Grant Date:
Apr 17, 2024
Title:
Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding Compositions
Applicant:
Patent:
Grant Date:
Feb 28, 2024
Title:
Nutritional Compositions Comprising Human Milk Oligosaccharides And Nucleotides And Uses Thereof For Treating And/Or Preventing Enteric Viral Infection
Patent:
Grant Date:
Jan 24, 2024
Title:
Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding Compositions
Applicant:
Patent:
Grant Date:
Nov 29, 2023
Title:
Oils With Anti-Inflammatory Activity Containing Natural Specialized Proresolving Mediators And Their Precursors
Applicant:
Patent:
Grant Date:
Aug 30, 2023
Title:
Human Dietary Supplement And Method For Treating Digestive System And Immune-Related Disorders
Patent:
Grant Date:
Aug 23, 2023
Title:
Methods Involving Neutrophil Elastase Inhibitor Alvelestat For Treating Respiratory Disease Mediated By Alpha-1 Antitrypsin Deficiency
Patent:
Grant Date:
Aug 2, 2023
Title:
Composition And Fodder Comprising Medium Chain Fatty Acids
Patent:
Grant Date:
Jul 12, 2023
Title:
Probiotic And Prebiotic Compositions, And Methods Of Use Thereof For Modulation Of The Microbiome
Patent:
Grant Date:
Jun 7, 2023
Title:
Emulsion
Applicant:

Top patents facing oppositions in Pain/inflammation Drugs industry

Patent
Grant Date
Nov 21, 2018
Title
Formulation Of Boronic Acid Compounds
Oppositions
11
Patent
Grant Date
Jul 27, 2022
Title
Use Of Dpp Iv Inhibitors
Oppositions
10
Patent
Grant Date
May 29, 2019
Title
(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof
Oppositions
10
Patent
Grant Date
Sep 6, 2017
Title
Inhibiting Inflammation With Milk Oligosaccharides
Oppositions
6
Patent
Grant Date
May 6, 2020
Title
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione
Oppositions
6
Patent
Grant Date
Jan 26, 2022
Title
Compositions Of Grapiprant And Methods For Using The Same
Oppositions
4
Patent
Grant Date
Mar 14, 2018
Title
Compositions Comprising Bacterial Strains
Oppositions
4
Patent
Grant Date
Jan 25, 2023
Title
Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis
Oppositions
4
Patent
Grant Date
Aug 1, 2018
Title
Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders
Oppositions
4
Patent
Grant Date
Nov 14, 2018
Title
Compositions Comprising Bacterial Strains
Oppositions
4

Need more information?

Feel free to send us a message here and we will get back to you